Meet the A. Alfred Taubman Medical Research Institute Management Team

Eva L. Feldman, MD, PhD, FAAN, FANA



Throughout her career, Dr. Eva Feldman, the Russell N. DeJong Professor of Neurology at the University of Michigan, has made it her mission to use scientific discoveries to understand and cure human diseases.

In January 2008, Dr. Feldman was named the first Director of the A. Alfred Taubman Medical Research Institute.  Under her leadership, the Taubman Institute funds senior-level clinician-scientists in a diverse spectrum of diseases – adult and childhood cancer, ALS, diabetes,cardiovascular disease and hearing loss. The institute also provides grants to early-career physician-researchers who are in the process of establishing their own laboratories.

In addition to running an active clinical practice at the University of Michigan, Dr. Feldman directs a team of 30 scientists who collaborate to understand and find new treatments for a wide variety of neuro degenerative conditions, including ALS, diabetic neuropathy, Alzheimer’s disease, and muscular dystrophies.

Martin Fischhoff

Managing Director


Marty Fischhoff joined the Taubman Institute in 2008 to oversee programming, operations, communications and development functions of the Taubman Institute. Prior to that, he was assistant managing editor at The Detroit News, where he worked for 20 years in a wide variety of capacities. He was the editor of Detroit Monthly for five years before that, winning the William White Award as editor of the best city magazine in its circulation class in the nation. He has worked in public relations, marketing, video production and wrote a best-selling guidebook to Detroit. He has participated in many community organizations, serving on the boards of Washtenaw Literacy, the International Institute of Metropolitan Detroit and D-PAN (which produces music videos for the deaf community).

Stacey Jacoby, PhD

Deputy Managing Director


Stacey Sakowski Jacoby, PhD, joined the Taubman Institute as the Deputy Managing Director in 2011.  Her role includes supporting the operation of the organization and managing scientific programs and communications of the Taubman Institute.
Dr. Jacoby received her PhD in Molecular Biology & Genetics from Wayne State University in 2006, where her graduate research training focused on the biochemical characterization and analysis of post-translational modifications of proteins involved in serotonin biosynthesis.  She joined the laboratory of Dr. Eva Feldman at the University of Michigan in 2006 as a postdoctoral research fellow, and then advanced to Research Investigator in 2011.  In the Feldman laboratory, she developed and utilized zebrafish models of amyotrophic lateral sclerosis (ALS) to understand the mechanisms of motor neuron degeneration and identify points for therapeutic intervention.  Dr. Jacoby is the author/co-author of over 30 manuscripts.